Literature DB >> 6272501

[Pharmacokinetics of ceftizoxim (author's transl)].

G Hitzenberger.   

Abstract

Ceftizoxim is a new cephalosporin derivative, which is also effective against anaerobic rods. The tolerability is excellent. Its pharmacokinetics after parenteral administration of 2 g were investigated in 12 healthy male volunteers. The half-life was 1.40 +/- 0.41 hours, the total clearance 194 l/min. The urinary excretion of the biological effective antibiotic amounted to 66.26 +/- 25.71%. These figures are in the same order of magnitude as those of older cephalosporins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272501

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  4 in total

1.  Pharmacokinetics of cefpirome (HR 810), a new cephalosporin derivative administered intramuscularly and intravenously to healthy volunteers.

Authors:  L Maass; V Malerczyk; M Verho
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

2.  [Clinical studies of the efficacy and tolerance of cefotaxime, ceftizoxime and ceftriaxone in patients with complicated urinary tract infections].

Authors:  M Westenfelder; K Pelz
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

3.  [Ceftizoxime concentration in blood, muscle, and kidney tissue].

Authors:  M Westenfelder; F Daschner; A Frankenschmidt
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

Review 4.  Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R C Heel
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.